Abstract Intraoral basal cell carcinoma
Introduction
Basal cell carcinoma (BCC) is considered to be the most common malignancy in humans and occurs primarily on the skin especially in the head and neck and accounts for approximately 75-80 % of all malignant diseases of skin [1] . Due to their high incidence rate, epidemiological studies to ascertain exact numbers are sparse [1] . The most recent estimate of non-melanoma skin cancers in the US for 2013 is 3.5 million, with the great majority of these being BCC [2] . The incidence of skin cancer is exponentially increasing worldwide, with some estimates reporting up to a 10 % annual increase in incidence [3] .
Intraoral basal cell carcinoma (IOBCC) is a controversial entity due to its rarity and histologic similarity to the peripheral ameloblastoma (PA). We describe three rare cases of IOBCC and discuss the salient histologic and clinical characteristics with an immunohistochemical staining profile. We review the reported cases of IOBCC in literature and differentiate this unusual entity from the peripheral ameloblastoma.
Case Report #1
A 39-year-old female presented to an oral and maxillofacial surgeon with a non-healing, painful erythematous growth on the anterior hard palatal mucosa, present for approximately 1 year. Clinical examination revealed an irregularly shaped, red to purple swelling extending from the mesiolingual papilla of tooth #4 to the lingual margin of tooth #9, measuring approximately 2.2 9 1.7 9 0. 2 cm (Fig. 1a) . The interproximal papilla between teeth #6 and #7 revealed a slight redness on the buccal aspect. An excisional biopsy was performed and diagnosed as a peripheral ameloblastoma. This diagnosis was rendered by another pathology service, and information on margins was not available in their report. The patient returned 3 weeks later with progressive erythema and swelling in the area of biopsy. The lesional area appeared to have enlarged and involved the papillary and palatal gingiva of several contiguous teeth (Fig. 1b) . At this time, an incisional biopsy was performed revealing multiple sections of a malignant neoplasm arising from the basal cell layer of surface epithelium invading into dense, desmoplastic appearing fibrous connective tissue (Fig. 2a) . The surface epithelium adjacent to the ulcerated and eroded zones did not demonstrate any dysplastic or atypical features. Islands of basaloid cells were seen budding off from the basal cell layer of the epithelium from the rete ridges over almost the entire length of the specimen. These islands contained numerous apoptotic cells, mitotic figures, and abundant mucoid stroma (Fig. 2b) . The peripheral cells of the islands displayed a palisaded arrangement with prominent retraction from the surrounding stroma (Fig. 2c) . The tumor was multifocal with areas exhibiting squamous differentiation with formation of occasional small keratin pearls. Immunohistochemical (IHC) stains (Table 1) for epithelial membrane antigen (EMA) and calretinin (to rule out a PA) were negative. Importantly, an IHC stain for Ber-EP4 was positive for the lesional cells in the invading tumor islands (Fig. 2d) . Based on the histologic features and IHC profile, a diagnosis of IOBCC was rendered. The lesion was excised with wide assured margins, and involved teeth numbers 5 through 9 were removed (Fig. 3a) . The mucosa was essentially stripped completely in the area using a carbon dioxide laser. Microscopic examination of the final excision revealed uninvolved margins and neoplastic proliferation very similar to those noted in the incisional biopsy. At 3 weeks' follow up, the patient was healing well but still in significant pain (Fig. 3b) . Five months later, an erythematous, linear area over the anterior palatal tissue was noted, and this lesion failed to resolve with antifungal therapy. An incisional biopsy to rule out recurrent IOBCC revealed non-specific inflammation, with no evidence of malignancy. The patient continues to be monitored for the last 3.5 years with no recurrence but does report atypical neuralgia secondary to the surgery.
Case Report #2
A 75 years old male presented to an oral and maxillofacial surgeon with an asymptomatic, indurated, slightly ulcerated swelling of 3 months' duration in the right retromolar pad, measuring approximately 1.0 9 0.6 9 0.4 cm. An incisional biopsy was performed and submitted for histopathologic examination. This incisional biopsy was diagnosed as a peripheral ameloblastoma. At the time of excisional biopsy (6 weeks later), the lesion had enlarged significantly, had remained ulcerated and the previous biopsy site had failed to heal (Fig. 4a) . The excisional biopsy revealed keratinized surface epithelium giving rise to a basaloid neoplasm exhibiting arborization and infiltrative rete ridges (Fig. 4b) . Multiple tumor islands consisting of hyperchromatic basophilic neoplastic cells were noted within the superficial lamina propria. The tumor islands exhibited a prominent palisading of peripheral basal cells, widespread extension into the underlying desmoplastic stroma, scattered mitotic figures, and mucoid ground substance (Fig. 4c) . IHC staining was performed (Table 1) with tumor islands exhibiting strong reactivity with Ber-EP4 and negative labeling for calretinin and EMA (Fig. 4d) .
A diagnosis of intraoral basal cell carcinoma was rendered. No recurrence was noted at the 1 year follow up.
Case Report #3
A 74-year-old female presented to an oral and maxillofacial surgeon with a painless 1.0 9 1.0 9 0.5 cm erythroleukoplakic area on the right buccal mucosa of approximately 6-12 months duration (Fig. 5a) . A past incisional biopsy in this area had been interpreted as ''ameloblastoma versus basal cell carcinoma''. An excisional biopsy was then performed. Histologic examination revealed multi-focal proliferations of basaloid epithelial cells that invaded the underlying fibrous connective tissue which displayed prominent desmoplasia (Fig. 5b) . The proliferative islands of neoplastic epithelium were contiguous with the basal layer of the surface epithelium. However, no atypia nor dysplasia of the surface epithelium was noted. The invasive nests demonstrated prominent, palisading layers of columnar cells with a basaloid appearance and displayed irregularly arranged, polygonal cells with relatively large, oval nuclei with vesicular chromatin (Fig. 5c ). Frequent mitotic figures, apoptotic cells, foci of squamous differentiation with some tumor nests forming small, pseudoductal structures containing a pale, mucoid product were observed. Margins were clear of tumor islands. Positive IHC labeling (Table 1) with Ber-EP4 was noted in the tumor islands ( Fig. 5d ), which were negative for calretinin and EMA. A final diagnosis of mucosal basal cell carcinoma was rendered. Five months after the excisional biopsy, the patient remains free of any recurrent lesion. 
Discussion
Basal cell carcinoma (BCC) of the oral cavity has been controversial entity for over half a century, dating back to the first published case of Saint in 1951 when he described basaloid lesions in the mid-dorsum of the tongue and soft palate in two patients [4] . However, many of the reports of IOBCC in literature have not been confirmed utilizing immunohistochemistry (Table 2 ). In 2001, Del Rosario et al. [5] reported the first well documented case of IOBCC on the buccal mucosa and confirmed their diagnosis utilizing Ber-EP4 antibody which produced positive labeling of the neoplastic basal cells, supporting an origin from the basal cell layer of the stratified squamous mucosa. Shumway et al. [6] also reported an additional case of IOBCC and reviewed past reports of IOBCC. They stressed the importance of accurate histologic diagnosis with positive Ber-EP4 labeling in confirming a diagnosis of IOBCC [6] . Ber-EP4 is a monoclonal antibody against cell surface glycoproteins (34 and 39 kDa) of most epithelial cells that reacts with epithelial tumors, with the exception of superficial layers of squamous epithelia [7] . Therefore, it reliably discriminates BCC from squamous cell carcinoma (SCC) and mesothelioma from adenocarcinoma [8, 9] . A recent study by Winters et al. [10] reported Ber-EP4 positivity in 82 % of basaloid SCC; however, BCC can be distinguished histologically from basaloid SCC. Ber-EP4 has been proven to be negative in peripheral ameloblastomas [11, 12] . Additionally, epithelial membrane antigen (EMA) a mucinlike glycoprotein often used as a pan-epithelial marker has been utilized to differentiate BCC from SCC, especially since some variants of SCC such as basaloid SCC may resemble BCC [13, 14] .
The histopathologic features of IOBCC are similar to those of cutaneous BCC [2, 15, 16] . IOBCC most closely resembles the peripheral ameloblastoma (PA) microscopically and is often misdiagnosed as PA, as noted in all three cases we present here. We contrast and compare the histologic features of IOBCC and PA in (Table 3 ). In 1911, Kuru reported an intraosseous ameloblastoma which had penetrated through the alveolar bone as a PA [17] . This cannot be considered a true PA since this case simply represented an extra-osseous presentation of an intraosseous lesion. In 1959, Stanley and Krogh published the first well documented report of PA with detailed clinical and pathological characteristics [18] . PAs are uncommon odontogenic tumors, accounting for approximately 1 % of all ameloblastomas. It has an innocuous clinical behavior, presenting as a slow-growing, firm, pink, painless mass with a sessile or pedunculated base with a smooth surface [19] . These are thought to arise from extraosseous rests of dental lamina (rests of Serres) beneath the oral mucosa or from surface epithelium having potential to differentiate into odontogenic epithelium, and usually occur in the mandible, particularly in the lingual premolar region or posterior gingival and alveolar mucosa [19] . Histopathologically, islands of ameloblastic epithelium with peripheral palisading, reverse polarity, and apical vacuolization of the nuclei are noted beneath the surface epithelium, with approximately 50 % of cases demonstrating connection of the tumor with the basal layer of the surface [11] . Immunohistochemically, ameloblastoma and PA stain with calretinin, also called calbindin-2 which is a 29-kDa calciumbinding protein [12] . It specifically labels the stellate reticulum cells of ameloblastoma and is considered an important IHC aid for detecting neoplastic ameloblastic epithelium. In addition, ameloblastomas react with anticytokeratin antibodies but not the anti-epithelial antibody Ber-EP4 [12, 20] . In contrast, tumor cells of BCC are positive for cytokeratin and Ber-EP4, while negative for EMA [15] . Vigneswaran et al. [21] reported positive peanut agglutinin staining in both PA and cutaneous BCC, speculating that PA and BCC may have same tissue of origin. However, other reports could not support this finding [22, 23] . Importantly, IOBCC is an invasive malignant neoplasm with potential of recurrence whereas PA are benign lesions with minimal destructive potential and low recurrence, therefore similarities between the two are difficult to establish.
Based on a careful review of the literature, we identified six cases of IOBCC supported by IHC (Table 2) . A female predilection with a ratio of 2:1 over males was found. The average age of presentation was 66, and the most common clinical presentation was a non-healing ulceration. The most common location is the buccal mucosa (4 of 6 cases, or 67 %), followed by the retromolar pad and hard palatal mucosa. In an excellent review, Shumway et al. [6] critically reviewed the cases listed in Table 2 and concluded that 6 of these cases were inadequately documented and did not support a diagnosis of BCC. They reviewed the photomicrographs available on other case reports and concluded that only one case may have represented a true BCC while the other cases may have been misdiagnosed. Clinically, IOBCC usually resembles a malignancy, specifically a carcinoma that may or not have associated leukoplakia and/or erythroplakia. We reviewed these cases as well and concur with Shumway et al. Our assessment of these reports concluded that 3 of the cases were inadequately documented with unclear photomicrographs [24] [25] [26] . We believe 6 of the cases have been diagnosed incorrectly and many of these would be better classified as PA or basaloid SCC [4, [27] [28] [29] [30] [31] . One case was a BCC of the skin [32] and another represented a metastatic BCC [33] . One case by Edmondson et al. [34] may have represented an IOBCC, but the lesion invaded into bone and no retraction artifact was noted. This case was interpreted as ameloblastic carcinoma by Shumway et al. [6] . A significant aspect in all three of our cases was the distinct lack of surface epithelial dysplasia. The neoplastic tissue appeared to arise from the basal cell layer with no evidence of atypical alterations of the rest of the epithelial layers. Moreover, the epithelium adjacent to the neoplastic proliferation also failed to display any dysplastic changes. This finding is also supported by recent literature [5, 6, 22] . This obvious lack of surface epithelial dysplasia and the fact that the neoplasm arises from the basal cell layer further supports origin from pluripotent basal cells [5, 6] .
A definitive mode of therapy has not yet been determined; however, according to the literature, the most common treatment consisted of wide local excision followed by close clinical follow up for at least a few years. IOBCC may exhibit signs of local recurrence and enlargement after conservative excision as in the case reported by Koutlas where multiple recurrences were noted [22] . The small series of confirmed IOBCC cases provide us with a 17 % recurrence rate (Table 2) .
Conclusions
Intraoral basal cell carcinoma (IOBCC) is a rare entity with histologic similarity to the peripheral ameloblastoma (PA). While the two lesions share many similar features, they are two distinct and separate entities. Ber-EP4 is considered to be a consistent and reliable marker in distinguishing between the two immunohistochemically. IOBCC appears to arise from pluripotent cells in the basal layer of stratified squamous mucosa with no evidence of surface epithelial dysplasia. Several of the prior reports of IOBCC have been 
